- $338.28m
- $133.14m
Brief: Zura Bio Says On Mar 24, Board Approved CEO Transition From Someit Sidhu To Robert Lisicki, Effective April 8
Zura Bio Ltd expected to post a loss of 23 cents a share - Earnings Preview
Brief: Zura Bio Appoints Robert Lisicki As President And Kiran Nistala As CMO
Brief: Athanor Capital Reports 11.01% Passive Stake In Zura Bio Limited As Of December 12
Brief: Zura Bio Q3 EPS USD -0.18
Zura Bio Ltd reports results for the quarter ended in June - Earnings Summary
Zura Bio Ltd expected to post a loss of 25 cents a share - Earnings Preview
Zura Bio Ltd expected to post a loss of 25 cents a share - Earnings Preview
Brief: Zura Bio To Join The Russell 2000® And Russell 3000® Indexes
Brief: Deep Track Capital Reports 9.39% Passive Stake In Zura Bio As Of June 5
U.S. STOCKS ON THE MOVE-Cenovus Energy, Compass Pathways,
U.S. STOCKS ON THE MOVE-NovoCure, Intuit, Splash Beverage
U.S. STOCKS ON THE MOVE-TScan Therapeutics, Palantir, Coinbase Global
U.S. STOCKS ON THE MOVE-Energy firms, GitLab, BrainStorm
Zura Bio rises on completing financing of $80 million
Brief: Zura Bio Completes Approximately $80 Million Financing With The Focus On Advancing Zb-106, A Potential First-In-Class Anti-Il-17 And Anti-Baff Dual Antagonist
U.S. STOCKS ON THE MOVE-Nvidia, GeoVax Labs, Freshpet
U.S. STOCKS ON THE MOVE-Citigroup, Tigo Energy, Children's Place
U.S. STOCKS ON THE MOVE-Shoe Carnival, Intuit, Abercrombie & Fitch